Otrivin nasal spray 0.1% 10 ml bottle with sprayer

• 1 ml of solution contains xylometazoline hydrochloride 1 mg;
• Excipients: sodium dihydrogen phosphate, dihydrate; sodium hydrogen phosphate, dodecahydrate; disodium edetate; benzalkonium chloride; sorbitol solution, non-crystallizing (E 420); hypromellose; sodium chloride; purified water.

Hypersensitivity to xylometazoline or to any other component of the drug, angle-closure glaucoma, transsphenoidal hypophysectomy and surgical interventions with exposure of the meninges in history, dry rhinitis (rhinitis sicca) or atrophic rhinitis.

The drug is used for adults and children over 12 years of age, 1 injection into each nasal passage up to 3 times a day. Apply no more than 3 times in each nasal passage per day. The duration of treatment depends on the course of the disease and should not exceed 7 consecutive days.

The metered spray ensures accurate dosing and proper distribution of the solution over the surface of the nasal mucosa. Each injection delivers 0.14 ml of solution, which corresponds to 0.14 mg of xylometazoline.

The duration of treatment should not exceed 7 days. Long-term treatment with xylometazoline may cause rhinitis medicamentosa and swelling of the nasal mucosa, which has symptoms similar to a cold.

Pregnant women

The drug should not be used during pregnancy due to its potential vasoconstrictor effect.

Children

The drug should not be used in children under 12 years of age.

Drivers

The drug usually has no or negligible influence on the ability to drive and use machines. With long-term use of high doses of xylometazoline, systemic effects with cardiovascular effects cannot be excluded.

Excessive topical application of xylometazoline hydrochloride or accidental ingestion may result in sympatholytic effects, including central nervous system depression (e.g. drowsiness, coma), severe dizziness, increased sweating, significant decrease in body temperature, pallor, headache, tachycardia, bradycardia, arterial hypertension, respiratory depression, miosis, convulsions, ataxia, anxiety.

Immune system disorders: hypersensitivity reactions, including angioedema, rash, itching.

From the nervous system: headache.

On the part of the organs of vision: temporary visual impairment.

Cardiovascular system: irregular or rapid heartbeat, hypertension, arrhythmia.

Respiratory, thoracic and mediastinal disorders: dryness or discomfort of the nasal mucosa, burning sensation, rhinitis medicamentosa.

Store out of the reach of children at a temperature not exceeding 30 °C.